Everolimus Plus Exemestane vs Everolimus or Capecitabine Monotherapy for Advanced Breast Cancer

This randomized clinical trial compares treatment with everolimus plus exemestane vs everolimus or capecitabine monotherapy for estrogen receptor-positive, HER2-negative advanced breast cancer.

https://ift.tt/2JbHGPO